Written by
Share article:
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced its next moves as the body seeks to bring greater regulatory scrutiny to generative AI’s use in healthcare.
The agency plans to launch a regulatory sandbox, dubbed the AI-Airlock, which will offer a regulator-monitored virtual area for developers to test their solutions and generate robust clinical evidence regarding performance.
The initiative comes as regulators around the world are busied with developing suitable regulations for AI tools, which allow the technology’s advantages to be realised, while still being able to oversee product deployment and ensuring that they are used appropriately.
Will the MHRA’s approach be enough to hasten the adoption of generative AI in the UK?
